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Abstract  Capsule  endoscopy  is  widely  accepted  as  the  preferred  diagnostic  test  in  the  evalua-
tion of  small  bowel  diseases,  especially  in  the  setting  of  obscure  gastrointestinal  bleeding.  It  has
revolutionized  small  bowel  examination  and  has  improved  the  detection  of  small  bowel  tumors.
However,  small  bowel  tumors  are  sometimes  missed  by  capsule  endoscopy.  Furthermore,  there
are several  recent  reports  comparing  capsule  endoscopy  with  other  diagnostic  modalities,  such
as double  balloon  enteroscopy  and  CT/RM  enterography,  that  challenge  the  reportedly  high
negative predictive  value  of  capsule  endoscopy  in  detecting  small  bowel  tumors.
We report  the  case  of  a  patient  with  overt  obscure  gastrointestinal  bleeding  due  to  a
gastrointestinal  stromal  tumor  diagnosed  by  CT  enterography  after  two  negatives  capsule
endoscopies.  This  case  shows  that  capsule  endoscopy  may  overlook  signiﬁcant  life  threaten-
ing lesions  and  highlights  the  importance  of  using  other  diagnostic  modalities  after  a  negative
capsule  endoscopy,  especially  in  patients  with  a  high  index  of  suspicion  for  small  bowel  tumoral
pathology  or  persistent/recurrent  bleeding.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
PALAVRAS-CHAVE A  Importância  da  Utilizac¸ão  de  Exames  Complementares  Alternativos  no  Diagnóstico
Endoscopia  por de  Tumores  do  Intestino  Delgado  Após  uma  Enteroscopia  por  Cápsula  Negativa
or  cápsula  é  um  dos  principais  métodos  de  diagnóstico  de  lesões  do
cial  no  contexto  da  hemorragia  digestiva  obscura.
ula  revolucionou  a  avaliac¸ão  do  intestino  delgado  e  a  detec¸ão  deCápsula;
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Resumo  A  enteroscopia  p
intestino  delgado,  em  espe
A enteroscopia  por  cápsNeoplasias  Intestinais tumores.  No  entanto,  os  tumores  do  intestino  delgado  nem  sempre  são  diagnosticados  por
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enteroscopia  por  cápsula.  Vários  artigos  que  comparam  a  enteroscopia  por  cápsula  com  outros
métodos  de  diagnóstico,  como  a  enteroscopia  por  duplo  balão  ou  a  enterograﬁa  por  tomograﬁa
computorizada/ressonância  colocam  em  causa  o  elevado  valor  preditivo  negativo  da  cápsula
endoscópica  na  detec¸ão  de  tumores  do  intestino  delgado.
Os autores  descrevem  o  caso  de  uma  doente  com  hemorragia  digestiva  obscura  manifesta
devido a  um  GIST  diagnosticado  por  enterograﬁa  por  TC  abdominal  após  realizac¸ão  de  duas
enteroscopias  por  cápsula  que  foram  negativas.  Este  caso  demonstra  que  a  enteroscopia  por
cápsula pode  não  diagnosticar  lesões  com  signiﬁcado  clinico  e  realc¸a  a  importância  de  utilizar
outros métodos  de  diagnóstico,  especialmente  em  doentes  com  elevado  índice  de  suspeic¸ão  de
tumores do  intestino  delgado  ou  hemorragia  persistente/recorrente.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.
Este é  um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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in  the  entire  small  bowel,  although  the  observation  of  the
ileum  was  hampered  by  some  luminal  content  (Fig.  1).  The
next  day,  after  transfusion  of  two  units  of  red  blood  cells,  she1. Introduction
Capsule  endoscopy  (CE)  became  a  ﬁrst-line  diagnostic  tool
in  obscure  gastrointestinal  bleeding  (OGIB)  and  has  gained
a  signiﬁcant  role  for  small  bowel  (SB)  tumor  detection  and
surveillance  in  polyposis  syndromes,  mostly  in  Peutz-Jeghers
syndrome  (PJS).1 CE  is  safe  and  non-invasive,  it  enables  visu-
alization  of  the  entire  small  bowel  and  has  been  shown  to
be  superior  to  push  enteroscopy,  small  bowel  follow-through
and  computed  tomography  in  detecting  small  bowel  bleed-
ing  lesions.2--4
In  OGIB,  a  negative  CE  has  been  associated  with  a  low
rebleeding  risk,  and  it  has  been  suggested  that  further  inves-
tigation  of  these  patients  can  be  reasonably  deferred  until
rebleeding  occurs.5,6 After  a  negative  surveillance  CE  in  PJS,
additional  investigations  must  only  be  performed  if  persist-
ing  clinical  symptoms  suggest  a  missed  lesion.
Although  highly  effective,  CE  has  technical  limitations,
which  increase  the  risk  of  missing  signiﬁcant  pathology:
incomplete  small-bowel  transit,  poor  luminal-view  quality,
visualization  of  only  the  mucosal  surface,  inadequate  lumi-
nal  distension  and  rapid  transit  through  the  duodenum  and
jejunum.  There  is  increasing  evidence  concluding  that  small
bowel  tumors  (SBT)  may  be  missed  by  CE  in  patients  with
OGIB  and  that  a  negative  CE  study  does  not  exclude  signif-
icant  disease,  suggesting  that  double-balloon  enteroscopy
and  CT/MR  enterography  should  be  considered  as  alternative
diagnostic  methods  when  clinical  suspicion  persists.7--9
2. Clinical case
A  46  year-old  woman  presented  to  the  emergency  depart-
ment  with  melena  and  marked  fatigue  for  1  week.  Two  years
before,  she  had  a  similar  clinical  episode  that  was  thought
to  be  caused  by  a  duodenal  ulcer  associated  with  Helicobac-
ter  pylori  (H.  pylori) infection.  10-day  sequential  treatment
was  indicated  and  a  subsequent  histology  was  negative  for
H.  pylori. The  patient  denied  abdominal  pain,  weight  loss
or  changes  in  bowel  habits.  She  was  not  taking  any  medi-
cation  including  nonsteroidal  anti-inﬂammatory  drugs.  She
F
ias  hemodynamically  stable  and  the  abdominal  examination
as  normal.
Laboratory  data  demonstrated  a  low  hemoglobin  level
6.8  g/dl);  white  blood  count,  liver  tests  and  C-reactive
rotein  were  in  the  normal  range.  Upper  gastrointestinal
ndoscopy  revealed  an  8  mm  Forrest  III  duodenal  ulcer;
here  was  no  blood  in  the  stomach  or  duodenum.  A  same
ay  colonoscopy  revealed  large  amounts  of  blood  in  the
olon  that  prevented  progression  beyond  the  splenic  ﬂexure,
ven  after  bowel  preparation.  The  next  day,  ileocolonoscopy
evealed  very  small  amounts  of  blood  in  the  ileum  and  colon
hat  were  easily  removed  by  water  and  no  lesions  in  the
olon  nor  in  the  distal  15  cm  of  ileum.  Based  on  these  results,
 CE  (after  12  h  of  fasting  and  without  bowel  preparation)
as  performed  36  h  later.  It  revealed  no  blood  or  lesionsigure  1  Capsule  endoscopy:  residual  luminal  content  in  the
leum.
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(Figures  2  and  3  CT  enterography:  Mesenteric  hyper
ad  no  more  gastrointestinal  bleeding  and  the  hemoglobin
evel  remained  stable  (9  g/dl).
One  month  later,  a  second  CE  was  performed  after  oral
ngestion  of  2  L  of  polyethylene  glycol.  As  in  the  ﬁrst  CE,
he  observation  of  the  ileum  was  also  hampered  by  resid-
al  luminal  content.  A  careful  retrospective  review  of  the
wo  CE  by  two  experienced  gastroenterologists  showed  no
esions  in  the  small  bowel.
Because  the  patient  maintained  iron-deﬁciency
nemia  (hemoglobin  =  10  g/dl;  serum  iron  =  21ug/dl;
erritin  =  12.3  ng/ml;  transferrin  =  9.1%)  despite  oral  iron
igure  4  Haphazardly  oriented  small  fascicles  and  turbinate
pindle-cell  without  pleomorphism  or  mitotic  activity  (HE,
00×).
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4lar  lesion  in  the  mid  ileum  (axial  and  coronal  views).
herapy,  a CT  enterography  was  performed.  It  revealed  a
9  mm  ×  39  mm  mesenteric  hypervascular  lesion  probably
ocated  in  the  mid  ileum,  with  homogeneous  contrast
nhancement,  although  its  intraluminal  or  extraluminal
ocation  was  impossible  to  deﬁne.  The  ﬁrst  diagnostic
ypothesis  was  a  gastrointestinal  stromal  tumor  (GIST)
Figs.  2  and  3).  The  patient  underwent  an  elective
aparoscopy,  in  which  a  3  cm  extraluminal  serosal  tumor
as  resected  from  the  mid  ileum;  the  respective  mucosa
ad  a  14  mm  procidentia  without  ulceration.  Microscopic
xamination  conﬁrmed  a  low  grade  GIST  (pT2N  ×  G1R0)
Figs.  4  and  5).
igure  5  Consistent  and  diffuse  CD117  reactivity  (CD117,
0×).
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3. Discussion
Small  bowel  tumors  (SBT)  such  as  carcinoids,  GIST  and  pri-
mary  and  metastatic  cancers  are  responsible  for  OGIB  in
up  to  10%  of  cases.10,11 CE  is  increasingly  used  to  detect
small-bowel  mass  lesions,  and  has  demonstrated  improved
sensitivity  compared  with  traditional  radiologic  techniques
for  SBT  detection.12,13 However,  several  recent  reports  after
the  development  of  new  alternative  endoscopic/imaging
techniques,  such  as  double  balloon  enteroscopy  and  CT/MR
enterography,  have  highlighted  potential  limitations  in  cap-
sule  technology,  particularly  in  the  identiﬁcation  of  SBT.
Postgate  et  al.1 reported  four  SBT  diagnosed  by  other  modal-
ities  after  being  missed  on  CE  (double  balloon  enteroscopy
in  2  patients,  CT  enterography  and  MR  enterography  in  the  2
remaining  patients).  Lewis  et  al.,14 in  a  review  of  pooled  CE
data,  reported  that  10%  of  SBT  were  missed  by  CE  and  were
identiﬁed  by  alternative  small  bowel  imaging  techniques.
Soares  et  al.15 found  that  up  to  20%  of  large  polyps  were
missed  by  CE  in  patients  with  PJS  and  Zagorowicz  et  al.9
concluded  that  neoplasms  may  be  missed  by  CE,  especially
in  the  proximal  small  bowel,  suggesting  that  in  some  cases
of  OGIB,  complementary  endoscopy  and/or  radiologic  test
may  be  indicated.
There  are  several  reasons  why  SBT  may  be  missed  by  CE.
CE  only  visualizes  the  luminal  surface  of  the  small  bowel,
and  unless  a  tumor  causes  mucosal  disruption,  it  may  go
undetected.16 Unlike  vascular  lesions,  that  may  be  present
throughout  the  small  bowel,  mass  lesions  are  typically  uni-
focal  and  at  the  current  image  capture  rate  of  2--4  frames
per  second,  focal  lesions  are  more  likely  to  be  missed  than
those  that  are  diffuse.  Moreover,  abnormalities  may  not  be
visualized  due  to  the  limitations  imposed  by  the  random
movement  of  the  capsule  during  transit  and  unidirectional
views.  But  even  large  tumors  may  be  missed  on  CE  as  showed
by  some  reports.1,17 Also,  the  rapid  transit  time  in  the
proximal  small  bowel,  angulations  and  folds  hiding  lesions,
incomplete  studies  to  the  cecum  and  poor  bowel  prepara-
tion  are  many  potential  reasons  why  false  negative  results
occur  with  CE.
Our  patient  had  two  episodes  of  gastrointestinal  bleed-
ing,  the  ﬁrst  attributed  to  a  duodenal  ulcer.  Two  years
later,  she  had  a  recurrence,  and  again,  upper  gastrointesti-
nal  endoscopy  revealed  a  duodenal  ulcer  with  the  same
characteristics  as  in  the  previous  episode.  However,  tak-
ing  into  account  that  this  was  the  second  bleeding  episode
not  totally  explained  by  a  Forrest  III  duodenal  ulcer,  a  CE
was  promptly  performed,  as  several  studies  have  proved
a  higher  diagnostic  and  therapeutic  yield  when  endoscopic
small  bowel  studies  are  performed  closer  to  the  bleeding
event.18
A  variety  of  lesions  may  result  in  small  bowel  bleeding,
with  the  etiology  being  different  in  various  age  groups:  in
elderly  patients  (>65  years  old)  vascular  lesions  (54%)  and
ulcers  are  the  common  causes;  in  the  middle  age  (41--64
years)  vascular  anomalies  (54.4%)  and  SBT  (31.3%)  are  the
major  causes,  and  in  young  adults  (<40  years)  the  leading
causes  are  Crohn’s  disease  (34.5%)  and  SBT.19,20 So,  consid-
ering  that  the  major  cause  of  OGIB  in  the  age  group  of  our
patient  is  a  vascular  lesion,  a  CE  was  performed.  It  was
ingested  in  the  ﬁrst  48  h  of  bleeding,  it  was  complete  to  the
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ecum  and  did  not  reveal  any  lesions;  however,  observation
f  the  ileum  was  hampered  by  some  luminal  content.
Management  of  patients  with  a  previous  negative  CE  is
ontroversial.  Few  studies  have  reported  on  repeat  CE  in
he  same  patient,  so  data  regarding  this  diagnostic  strategy
s  limited.  Svarta  et  al.21 conclude  that  repeat  CE  appears
o  be  of  beneﬁt  in  patients  with  a  previous  incomplete
tudy  or  poor  bowel  preparation  before  subsequent  SB  stud-
es.  The  American  Society  of  Gastrointestinal  Endoscopy22
ecommends  to  repeat  CE  or  to  perform  deep  enteroscopy
n  patients  with  a  history  of  recent  overt  OGIB  who  now  have
o  evidence  of  ongoing  bleeding.  However,  other  options  like
T  enterography  should  be  considered.
Because  small  bowel  visualization  was  limited  by  lumi-
al  content,  a  second  CE  was  performed  some  weeks  later,
efore  CT  enterography  was  considered.  But  even  after
ngesting  2  L  of  polyethylene  glycol  the  evening  before  the
rocedure,  there  still  was  some  residual  luminal  small  bowel
ontent.  Both  CE  were  reviewed  by  two  experienced  gas-
roenterologists  that  did  not  identify  the  lesion.  Poor  bowel
isualization,  in  addition  to  the  fact  that  the  GIST  had  a  pre-
ominantly  extraluminal  location  with  only  a  small  mucosal
rocidentia  without  ulceration,  may  have  contributed  to
iss  the  underlying  mass  lesion  on  both  CE.  Whatever  the
eason  for  false  negatives,  our  case  demonstrates  that  CE
ay  overlook  signiﬁcant  life  threatening  lesions  and  cast
oubt  on  the  high  negative  predictive  value  of  CE.
Less  invasive  tests  may  be  useful  to  evaluate  OGIB  after
 negative  CE.  In  our  patient,  SBT  was  only  detected  by
T  enterography.  Postgate  et  al.1 also  described  a  patient
ith  a  large  gastrointestinal  stromal  tumor  only  detected  by
T  enterography.  CT  enterography  or  MR  enterography  can
e  alternative  techniques  to  identify  SB  lesions  that  have  a
redominantly  extraluminal  rather  than  intraluminal  com-
onent.  However,  CT  enterography  has  some  limitations,
specially  in  patients  intolerant  to  oral  contrast,  with  GI
ysmotility  and  with  inadequate  bowel  distention  secondary
o  bowel  obstruction.  Furthermore,  CT  enterography  can
iss  ﬂat  lesions  like  angiodysplasias,  dieulafoy’s  lesions  and
lcers,  which  can  be  better  detected  by  CE.  On  the  other
ide,  in  a  recent  report,  a  large  jejunal  polyp  was  found  on
E  in  a  patient  with  PJS  that  was  previously  missed  in  CT
nterography.23
In  most  comparative  studies,  CE  has  been  proved  to  be
uperior  to  CT  in  the  evaluation  of  OGIB.  However,  in  a
ecent  prospective  study  comparing  CE  and  multiphase  CT
nterography  in  OGIB  the  authors  showed  that  the  sensiv-
ty  of  CT  enterography  in  identifying  small  bowel  bleeding
as  superior  to  CE  (88%  vs  38%,  p  =  0.008).7 The  improved
ensitivity  of  CT  enterography  in  this  study  was  mostly  due
o  improved  detection  of  SBT,  with  CE  depicting  only  three
f  the  nine  lesions  identiﬁed  in  CT  enterography.  In  another
linded  prospective  study,  CT  enterography  detected  9/9
100%)  SBT  compared  with  2/9  (22%)  by  CE.24 Other  investi-
ators  have  also  shown  that  CE  may  fail  to  depict  clinically
igniﬁcant  small  bowel  masses,  particularly  as  some  SBT  such
s  carcinoids  or  GIST  may  not  have  a  mucosal  component.1
ut  even  large  lesions  can  be  missed.  Grupta  et  al.25 found
hat  CT  enterography  may  be  less  prone  to  miss  large  polyps
han  CE  in  patients  with  PJS  and  may  be  more  reliable  in
heir  assessment.
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Although  CE  has  greatly  facilitated  SB  imaging  and  is  con-
idered  the  gold  standard  in  evaluating  patients  with  SB
isease,  especially  those  with  OGIB,  this  case  shows  that  CE
ay  overlook  signiﬁcant  life  threatening  lesions  and  high-
ights  the  importance  of  using  other  diagnostic  modalities
fter  a  negative  CE  in  patients  with  a  high  index  of  suspicion
or  small  bowel  tumoral  pathology  or  persistent/recurring
leeding.  In  younger  patients,  where  SBT  are  one  of  the  most
mportant  causes  of  OGIB,  CT  enterography  should  be  con-
idered  the  ﬁrst  diagnostic  test  for  small  bowel  evaluation
fter  a  negative  CE.
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